Treprostinil Diolamine Patent Expiration
Treprostinil Diolamine is Used for treating pulmonary arterial hypertension (WHO Group 1) with oral osmotic pharmaceutical dosage forms of treprostinil. It was first introduced by United Therapeutics Corp
Treprostinil Diolamine Patents
Given below is the list of patents protecting Treprostinil Diolamine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Orenitram | US8747897 | Osmotic drug delivery system | Aug 11, 2031 | United Therap |
| Orenitram | US8349892 | Solid formulations of prostacyclin analogs | Jan 22, 2031 | United Therap |
| Orenitram | US8410169 | Compounds and methods for delivery of prostacyclin analogs | Feb 13, 2030 | United Therap |
| Orenitram | US11723887 | Process to prepare treprostinil, the active ingredient in Remodulin® | Dec 15, 2028 | United Therap |
| Orenitram | US8497393 | Process to prepare treprostinil, the active ingredient in Remodulin® | Dec 15, 2028 | United Therap |
| Orenitram | US9593066 | Process to prepare treprostinil, the active ingredient in remodulin® | Dec 15, 2028 | United Therap |
| Orenitram | US9604901 | Process to prepare treprostinil, the active ingredient in Remodulin® | Dec 15, 2028 | United Therap |
| Orenitram | US7417070 | Compounds and methods for delivery of prostacyclin analogs | Jul 30, 2026 | United Therap |
| Orenitram | US9393203 | Osmotic drug delivery system | Apr 27, 2026 | United Therap |
| Orenitram | US7544713 | Compounds and methods for delivery of prostacyclin analogs |
Jul 14, 2024
(Expired) | United Therap |
| Orenitram | US8252839 | Compounds and methods for delivery of prostacyclin analogs |
May 24, 2024
(Expired) | United Therap |
| Orenitram | US9050311 | Compounds and methods for delivery of prostacyclin analogs |
May 24, 2024
(Expired) | United Therap |
| Orenitram | US9278901 | Compounds and methods for delivery of prostacyclin analogs |
May 24, 2024
(Expired) | United Therap |
| Orenitram | US9422223 | Compounds and methods for delivery of prostacyclin analogs |
May 24, 2024
(Expired) | United Therap |
| Orenitram | US6765117 | Process for stereoselective synthesis of prostacyclin derivatives |
Oct 24, 2017
(Expired) | United Therap |
| Orenitram | US5153222 | Method of treating pulmonary hypertension with benzidine prostaglandins |
Oct 16, 2014
(Expired) | United Therap |
Treprostinil Diolamine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List